About ReNu® ReNu is a cryopreserved, amniotic suspension allograft developed for the management of symptomatic knee osteoarthritis. ReNu consists of amniotic fluid cells and micronized amniotic ...

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at ...

Attention gardeners, it’s time to sign up for the 2026 West Hawaii Master Gardener Training Program. This educational ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product ...

Popular Latter-day Saint apostle Jeffrey R. Holland, known for his powerful and poetic sermons, has died at age 85 from ...

Autonomous free-flying robots aboard the International Space Station (ISS) frequently lose their bearings. Without gravity to distinguish up from down, even precision sensors suffer from accumulating ...

The launch of island-wide special customs operations at South China's Hainan Free Trade Port represents a major strategic ...

NIS2 is in effect and the to-do list for CISOs is exploding. The frequent result: unclear requirements, a huge documentation ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Recently, Beijing Economic-Technological Development Area (Beijing E-Town) issued the "Several Measures on Accelerating the Cultivation of the Future Energy Industry." Focusing on clean energy sectors ...

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

MacCubbin gives gardening advice for Central Florida about tea plants, annuals like coleus, ligustrum, figs, broccoli, palms and weed control ...